Investigating the potential non-authorized use of two different formulations of liraglutide in Europe: A real-world drug utilization study.
Paolo SbracciaJens AberleAnne Helene OlsenNaveen RathorAtheline Major-PedersenPublished in: Diabetes, obesity & metabolism (2022)
gov identifier: NCT02967757. This article is protected by copyright. All rights reserved.